Skip to main content
eScholarship
Open Access Publications from the University of California

Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials.

  • Author(s): Flannery, Erika L
  • McNamara, Case W
  • Kim, Sang Wan
  • Kato, Tomoyo Sakata
  • Li, Fengwu
  • Teng, Christine H
  • Gagaring, Kerstin
  • Manary, Micah J
  • Barboa, Rachel
  • Meister, Stephan
  • Kuhen, Kelli
  • Vinetz, Joseph M
  • Chatterjee, Arnab K
  • Winzeler, Elizabeth A
  • et al.

Published Web Location

https://doi.org/10.1021/cb500616x
Abstract

Aminopyrazoles are a new class of antimalarial compounds identified in a cellular antiparasitic screen with potent activity against Plasmodium falciparum asexual and sexual stage parasites. To investigate their unknown mechanism of action and thus identify their target, we cultured parasites in the presence of a representative member of the aminopyrazole series, GNF-Pf4492, to select for resistance. Whole genome sequencing of three resistant lines showed that each had acquired independent mutations in a P-type cation-transporter ATPase, PfATP4 (PF3D7_1211900), a protein implicated as the novel Plasmodium spp. target of another, structurally unrelated, class of antimalarials called the spiroindolones and characterized as an important sodium transporter of the cell. Similarly to the spiroindolones, GNF-Pf4492 blocks parasite transmission to mosquitoes and disrupts intracellular sodium homeostasis. Our data demonstrate that PfATP4 plays a critical role in cellular processes, can be inhibited by two distinct antimalarial pharmacophores, and supports the recent observations that PfATP4 is a critical antimalarial target.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View